Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

News und Analysen

AMN Healthcare Named as One of America’s Most Responsible Companies for 2022: https://mms.businesswire.com/media/20201201005032/en/841855/5/AMN-Logo.jpg
AMN Healthcare Named as One of America’s Most Responsible Companies for 2022


For the third year in a row, AMN Healthcare (NYSE: AMN) has been named one of the country’s most responsible companies by Newsweek and Statista Action for its commitment and action to promote

Vifor Pharma appoints two new members to the Executive Committee: https://mms.businesswire.com/media/20191103005014/en/691947/5/VP_logo_rgb.jpg
Vifor Pharma appoints two new members to the Executive Committee


Regulatory News:



AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR



Vifor Pharma Group today announced the appointment of acting Chief Financial Officer Alexandros Sigalas and Group General Counsel Dr

Premier, Inc. Reports Fiscal Year 2022 Second Quarter Results: https://mms.businesswire.com/media/20191105005372/en/754182/5/PR_LogoSpec_%282%29.jpg
Premier, Inc. Reports Fiscal Year 2022 Second Quarter Results


Premier, Inc. (NASDAQ: PINC), a leading technology-driven healthcare improvement company, today reported financial results for the fiscal year 2022 second quarter ended December 31, 2021.



"Our

AMN Healthcare Again Recognized for Workplace Equity and Social Justice by Two Major Corporate Equality Indexes: https://mms.businesswire.com/media/20201201005032/en/841855/5/AMN-Logo.jpg
AMN Healthcare Again Recognized for Workplace Equity and Social Justice by Two Major Corporate Equality Indexes


AMN Healthcare’s commitment to diversity, equity, equality, and inclusion has again been recognized in the business world with the company’s listing in two top corporate indexes that measure

Human Rights Campaign und Bloomberg würdigen QIAGENs Engagement im Bereich LGBTQ+- und Geschlechtergleichstellung
Human Rights Campaign und Bloomberg würdigen QIAGENs Engagement im Bereich LGBTQ+- und Geschlechtergleichstellung


QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) gab heute bekannt, dass das Engagement des Unternehmens für mehr Vielfalt und Gleichstellung von Geschlechtern am Arbeitsplatz durch die

QIAGEN’s Commitment to LGBTQ+ and Gender Equality Recognized by Human Rights Campaign and Bloomberg Indexes
QIAGEN’s Commitment to LGBTQ+ and Gender Equality Recognized by Human Rights Campaign and Bloomberg Indexes


QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that its commitment to workplace diversity and gender equality has been recognized by inclusion in the U.S. LGBTQ+ Corporate

Gerresheimer AG: Der führende Anbieter von Injektionsfläschchen Gerresheimer erweitert Produktion in Wertheim: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23715/Gerresheimer_logo.svg.png
Gerresheimer AG: Der führende Anbieter von Injektionsfläschchen Gerresheimer erweitert Produktion in Wertheim
Gerresheimer AG: Der führende Anbieter von Injektionsfläschchen Gerresheimer erweitert Produktion in Wertheim
Gerresheimer AG: The leading supplier of injection vials Gerresheimer expands production in Wertheim: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23715/Gerresheimer_logo.svg.png
Gerresheimer AG: The leading supplier of injection vials Gerresheimer expands production in Wertheim
Gerresheimer AG: The leading supplier of injection vials Gerresheimer expands production in Wertheim
Charles River Expands Strategic Partnership With SAMDI Tech: https://mms.businesswire.com/media/20191106005189/en/754630/5/charles_river_logo.jpg
Charles River Expands Strategic Partnership With SAMDI Tech


Charles River Laboratories International, Inc. (NYSE: CRL) today announced the expansion of their strategic partnership with Chicago, Illinois-based SAMDI Tech, Inc. Under the existing partnership

AMN Healthcare Commitment Supports Underserved Nurses and Nurse Wellness: https://mms.businesswire.com/media/20201201005032/en/841855/5/AMN-Logo.jpg
AMN Healthcare Commitment Supports Underserved Nurses and Nurse Wellness


In line with its commitment to the health and wellbeing of nurses, and for advancing diversity, equality, equity, and inclusion in the nursing profession, AMN Healthcare is donating to support the

QIAGEN Completes U.S. Federal Contract to Equip Local Public Health Authorities with QIAcuity Digital PCR System for COVID-19 Surveillance
QIAGEN Completes U.S. Federal Contract to Equip Local Public Health Authorities with QIAcuity Digital PCR System for COVID-19 Surveillance


QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced it has completed a U.S. government contract to equip public health laboratories across the country with the QIAcuity digital

QIAGEN rüstet im Auftrag von US-Bundesbehörde lokale Gesundheitslabore mit digitalem PCR-System QIAcuity für die COVID-19 Überwachung aus
QIAGEN rüstet im Auftrag von US-Bundesbehörde lokale Gesundheitslabore mit digitalem PCR-System QIAcuity für die COVID-19 Überwachung aus


QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) gab heute bekannt, im Rahmen der Erfüllung eines mit der US-Regierung geschlossenen Vertrags das digitale PCR-System QIAcuity landesweit an

DGAP-News: Evotec enters iPSC-based drug discovery partnership with Boehringer Ingelheim in ophthalmology : http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23749/Evotec_high_res_logo_%28blue_and_grey%29.jpg
DGAP-News: Evotec enters iPSC-based drug discovery partnership with Boehringer Ingelheim in ophthalmology
DGAP-News: Evotec enters iPSC-based drug discovery partnership with Boehringer Ingelheim in ophthalmology
DGAP-News: Evotec geht iPSC-basierte Forschungspartnerschaft mit Boehringer Ingelheim im Bereich Augenheilkunde ein: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23749/Evotec_high_res_logo_%28blue_and_grey%29.jpg
DGAP-News: Evotec geht iPSC-basierte Forschungspartnerschaft mit Boehringer Ingelheim im Bereich Augenheilkunde ein
DGAP-News: Evotec geht iPSC-basierte Forschungspartnerschaft mit Boehringer Ingelheim im Bereich Augenheilkunde ein
DGAP-News: Frauenanteil in Führungspositionen: MorphoSys Nummer 1 in Deutschland im European Women on Boards Gender Equality Index Report: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24061/Morphosys-logo.svg.png
DGAP-News: Frauenanteil in Führungspositionen: MorphoSys Nummer 1 in Deutschland im European Women on Boards Gender Equality Index Report
DGAP-News: Frauenanteil in Führungspositionen: MorphoSys Nummer 1 in Deutschland im European Women on Boards Gender Equality Index Report
DGAP-News: MorphoSys ranked Number One in Germany for Female Representation at Leadership Level in European Women on Boards' Gender Equality Index Report: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24061/Morphosys-logo.svg.png
DGAP-News: MorphoSys ranked Number One in Germany for Female Representation at Leadership Level in European Women on Boards' Gender Equality Index Report
DGAP-News: MorphoSys ranked Number One in Germany for Female Representation at Leadership Level in European Women on Boards' Gender Equality Index Report
AMN Healthcare to Hold Fourth Quarter and Full Year 2021 Earnings Conference Call on Thursday, February 17, 2022: https://mms.businesswire.com/media/20201201005032/en/841855/5/AMN-Logo.jpg
AMN Healthcare to Hold Fourth Quarter and Full Year 2021 Earnings Conference Call on Thursday, February 17, 2022


AMN Healthcare Services, Inc. (NYSE: AMN), has scheduled a conference call to discuss its fourth quarter and full year 2021 financial results and first quarter 2022 outlook on Thursday, February

Premier, Inc. Declares Quarterly Cash Dividend: https://mms.businesswire.com/media/20191105005372/en/754182/5/PR_LogoSpec_%282%29.jpg
Premier, Inc. Declares Quarterly Cash Dividend


Premier, Inc. (NASDAQ: PINC), a leading technology-driven healthcare improvement company, today announced that its Board of Directors declared a cash dividend of $0.20 per share of Class A common

Charles River Laboratories Schedules Fourth-Quarter 2021 Earnings Release and Conference Call: https://mms.businesswire.com/media/20191106005189/en/754630/5/charles_river_logo.jpg
Charles River Laboratories Schedules Fourth-Quarter 2021 Earnings Release and Conference Call


Charles River Laboratories International, Inc. (NYSE: CRL) will release fourth-quarter and full-year 2021 financial results on Wednesday, February 16th, before the market opens. A conference call

Charles River and Valo Health Announce Strategic Partnership to Provide Clients with Access to AI-Enabled Drug Discovery Solutions: https://mms.businesswire.com/media/20191106005189/en/754630/5/charles_river_logo.jpg
Charles River and Valo Health Announce Strategic Partnership to Provide Clients with Access to AI-Enabled Drug Discovery Solutions


Charles River Laboratories International, Inc. (NYSE: CRL) and Valo Health, LLC (“Valo”), the technology company using human-centric data and computation powered by artificial intelligence (AI) to

QIAGEN N.V. to release results for Q4 2021 and Full-Year of 2021
QIAGEN N.V. to release results for Q4 2021 and Full-Year of 2021


QIAGEN N.V. (NYSE: QGEN) (Frankfurt Stock Exchange: QIA) announced today that it plans to release its report on results for the fourth quarter and full-year results of 2021 on Tuesday, February 8

VFMCRP receives EU approval for Tavneos® for the treatment of ANCA-associated vasculitis: https://mms.businesswire.com/media/20191103005014/en/691947/5/VP_logo_rgb.jpg
VFMCRP receives EU approval for Tavneos® for the treatment of ANCA-associated vasculitis


Regulatory News:



Vifor Fresenius Medical Care Renal Pharma (VFMCRP) today announced that the European Commission has approved Tavneos® in combination with a rituximab or cyclophosphamide regimen

QIAGEN Launches QIAwave Portfolio of Environmentally Friendly Products
QIAGEN Launches QIAwave Portfolio of Environmentally Friendly Products


QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced its new QIAwave product line by launching three nucleic acid extraction kits that use fewer components and produce less waste

QIAGEN führt mit QIAwave umweltfreundliche Produktlinie ein
QIAGEN führt mit QIAwave umweltfreundliche Produktlinie ein


QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) gab heute die Einführung seiner neuen Produktlinie QIAwave und der ersten drei QIAwave Nukleinsäure-Extraktionskits bekannt. Diese neuen Kits

PINC AI™ Launches INsights, an Enhanced Technology Offering for Customized, On-Demand Healthcare Analytics: https://mms.businesswire.com/media/20191105005372/en/754182/5/PR_LogoSpec_%282%29.jpg
PINC AI™ Launches INsights, an Enhanced Technology Offering for Customized, On-Demand Healthcare Analytics


PINC AI™, the technology and services platform of Premier, Inc (NASDAQ: PINC), today launched INsights, an enhanced self-service healthcare solution for the creation of customized, on-demand